Cervix BT - 2016

Dose in D90 and HR CTV for point A prescription High Target Doses in small tumours Low Target Doses in large tumours

140

Standard

100 110 120 130

60 70 80 90

HR-CTV D90 standard

50

0 10 20 30 40 50 60 70 80 90 100 110 Volume HR CTV, cm 3

39 K Tanderup et al, Radiother Oncol 2010 Tanderup et al.

Violation of OAR constraint

Made with